{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T04:12:09Z","timestamp":1794370329725,"version":"4.9.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T00:00:00Z","timestamp":1716681600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Idiopathic inflammatory myopathies (IIM) can present with acute IIM-related lung injury and respiratory failure, leading to a high mortality risk in intensive care units (ICU). Extracorporeal membrane oxygenation (ECMO) in acute respiratory distress syndrome can be lifesaving. We aimed to report a case series of IIM patients that received ECMO.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patients with IIM from tertiary care centres in Belgium, Canada, Denmark, USA and Sweden who underwent ECMO were reviewed to describe clinical characteristics, disease outcomes and hospitalization course. Clinical characteristics at admission and during ICU stay including ECMO complications and mortality causes were summarized.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The study included 22 patients (50% female, mean\u2009\u00b1\u2009SD age at admission 47\u2009\u00b1\u200912\u2009years) with anti-MDA5 positive dermatomyositis (68%), anti-synthetase syndrome (14%), polymyositis (9%), overlap myositis (5%) and non-MDA5 dermatomyositis (5%). Patients had low comorbidity scores and 46% had received immunosuppression before their ICU admission. Eight (36%) patients died in the ICU, six (27%) were bridged to recovery and eight (36%) were bridged to transplant. When comparing patients bridged to recovery and those who died in the ICU, those who died were older (P\u2009=\u20090.03) and had higher median Charlson comorbidity index scores (P\u2009=\u20090.05). Both groups had similar frequencies of ECMO-related complications (33% vs 50%, P\u2009=\u20090.94).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>In the patients exposed to ECMO in this case series, 14 were successfully bridged to recovery or transplant, while 8 died in the ICU. Large studies are needed to collect data on clinical outcomes in patients with IIM-ILD exposed to ECMO to identify the best candidates for the intervention.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae311","type":"journal-article","created":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T03:28:02Z","timestamp":1716694082000},"page":"2204-2208","source":"Crossref","is-referenced-by-count":9,"title":["Extracorporeal membrane oxygenation for acute lung injury in idiopathic inflammatory myopathies\u2014a potential lifesaving intervention"],"prefix":"10.1093","volume":"64","author":[{"given":"Boyang","family":"Zheng","sequence":"first","affiliation":[{"name":"Division of Rheumatology, University of British Columbia , Vancouver,","place":["Canada"]},{"name":"Division of Rheumatology, McGill University Health Centre , Montreal,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Eline","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Xu","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Huang","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, University of British Columbia , Vancouver,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5340-1500","authenticated-orcid":false,"given":"Greet","family":"Hermans","sequence":"additional","affiliation":[{"name":"Medical Intensive Care Unit, University Hospitals Leuven , Leuven,","place":["Belgium"]},{"name":"Department of Cellular and Molecular Medicine , KU Leuven, Leuven,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9740-1246","authenticated-orcid":false,"given":"Michael","family":"Perch","sequence":"additional","affiliation":[{"name":"Division of Lung Transplantation, Heart Center, Rigshospitalet , Copenhagen,","place":["Denmark"]},{"name":"Department of Clinical Medicine, University of Copenhagen , Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordan","family":"Samoukovic","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, McGill University Health Centre , Montreal,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4045-2146","authenticated-orcid":false,"given":"Ellen","family":"De Langhe","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, University Hospitals Leuven , Leuven,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Dastmalchi","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Karolinska Institutet , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7150-7306","authenticated-orcid":false,"given":"Lisa","family":"Christopher-Stine","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2581-8912","authenticated-orcid":false,"given":"Louise Pyndt","family":"Diederichsen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Odense University Hospital , Odense,","place":["Denmark"]},{"name":"Department of Rheumatology , Rigshospitalet, Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8643-6697","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Leclair","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Jewish General Hospital , Montreal,","place":["Canada"]},{"name":"Lady Davis Institute for Medical Research , Montreal,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,25]]},"reference":[{"key":"2025040212090291200_keae311-B1","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s00296-019-04398-2","article-title":"Clinical spectrum and therapeutics in Canadian patients with anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis: a case-based review","volume":"39","author":"Huang","year":"2019","journal-title":"Rheumatol Int"},{"key":"2025040212090291200_keae311-B2","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1007\/s00134-020-06248-3","article-title":"ECMO for severe ARDS: systematic review and individual patient data meta-analysis","volume":"46","author":"Combes","year":"2020","journal-title":"Intensive Care Med"},{"key":"2025040212090291200_keae311-B3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"2025040212090291200_keae311-B4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13613-018-0433-3","article-title":"Clinical features and outcome of patients with acute respiratory failure revealing anti-synthetase or anti-MDA-5 dermato-pulmonary syndrome: a French multicenter retrospective study","volume":"8","author":"Vuillard","year":"2018","journal-title":"Ann Intensive Care"},{"key":"2025040212090291200_keae311-B5","first-page":"2526","article-title":"Acute respiratory distress syndrome: the Berlin Definition","volume":"307","author":"Ranieri","year":"2012","journal-title":"JAMA"},{"key":"2025040212090291200_keae311-B6","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2016.0291","article-title":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries","volume":"315","author":"Bellani","year":"2016","journal-title":"JAMA"},{"key":"2025040212090291200_keae311-B7","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/rheumatology\/keac450","article-title":"Time-dependent changes in RPILD and mortality risk in anti-MDA5+ DM patients: a cohort study of 272 cases in China","volume":"62","author":"You","year":"2022","journal-title":"Rheumatology"},{"key":"2025040212090291200_keae311-B8","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1056\/NEJMoa1800385","article-title":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome","volume":"378","author":"Combes","year":"2018","journal-title":"N Engl J Med"},{"key":"2025040212090291200_keae311-B9","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1164\/rccm.201806-1094OC","article-title":"Mechanical ventilation management during extracorporeal membrane oxygenation for acute respiratory distress syndrome. An international multicenter prospective cohort","volume":"200","author":"Schmidt","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2025040212090291200_keae311-B10","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.chest.2021.06.075","article-title":"Veno-venous extracorporeal membrane oxygenation for myositis-associated rapidly progressive interstitial lung disease","volume":"160","author":"Rubin","year":"2021","journal-title":"Chest"},{"key":"2025040212090291200_keae311-B11","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.chest.2017.03.033","article-title":"The role of infection in interstitial lung diseases: a review","volume":"152","author":"Azadeh","year":"2017","journal-title":"Chest"},{"key":"2025040212090291200_keae311-B12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fmed.2017.00176","article-title":"Acute exacerbation in interstitial lung disease","volume":"4","author":"Leuschner","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"2025040212090291200_keae311-B13","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1111\/ajt.17177","article-title":"Lung transplantation for interstitial lung disease in idiopathic inflammatory myositis: a cohort study","volume":"22","author":"Riviere","year":"2022","journal-title":"Am J Transplant"},{"key":"2025040212090291200_keae311-B14","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.healun.2019.08.004","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult lung and heart-lung transplantation Report-2019; Focus theme: donor and recipient size match","volume":"38","author":"Khush","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"2025040212090291200_keae311-B15","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.chest.2020.01.033","article-title":"Recognition and management of myositis-associated rapidly progressive interstitial lung disease","volume":"158","author":"Jablonski","year":"2020","journal-title":"Chest"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae311\/58177581\/keae311.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/4\/2204\/58177581\/keae311.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/4\/2204\/58177581\/keae311.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T15:55:26Z","timestamp":1743609326000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/4\/2204\/7682385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,25]]},"references-count":15,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,5,25]]},"published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae311","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,5,25]]}}}